Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Sherry Winter

Sherry Winter

Senior Solution Marketing Manager

Connect with Sherry Winter on LinkedIn

About the author:

As a Senior Solution Marketing Manager at Elsevier, Sherry is responsible for delivering insights on markets and customers, messaging, positioning and thought leadership for life science solutions, including PharmaPendium, that enable Drug Discovery and Development and Pharmacovigilance.

Sherry has a PhD in Medical Genetics from the University of Toronto, Canada and has several years of experience in life science marketing and communications, having worked at QIAGEN in Hilden, Germany before joining Elsevier and also in Research Communications at the University Health Network in Toronto, Canada. Prior to this, Sherry performed research at cancer institutes in both Canada and the US.

Posts by Sherry Winter

Assessing DDI Risk in the Digital Age

Posted on August 9th, 2017 in Pharmacovigilance

pills pic for SD case study
In their 2012 Drug Regulations, the U.S. Food and Drug Administration recommended that “pharmacokinetic interactions between an investigational new drug and other drugs should be defined during drug development.”

Continue reading “Assessing DDI Risk in the Digital Age” »

The Value of Drug–Drug Interaction Risk Assessments

Posted on June 28th, 2017 in Pharma R&D

Should a drug candidate move on to pre-clinical and clinical trials? It’s a question that every pharmaceutical developer must face, and the earlier they can answer it, the better in terms of use of time and effort. Continue reading “The Value of Drug–Drug Interaction Risk Assessments” »

Targeting Rare Diseases

Posted on March 20th, 2017 in Pharma R&D

What is known as a “rare” disease might affect anywhere between a couple hundred to a couple hundred thousand people here in the U.S. And it’s estimated that as much as 10% of the nation’s population has one of the thousands of known rare diseases, most of which are genetic. Continue reading “Targeting Rare Diseases” »

Finding Adverse Event Data on Social Media

Posted on September 19th, 2016 in Pharmacovigilance

Have you ever complained about an unpleasant health issue (maybe a strange ache or sudden difficulty sleeping) on your Facebook page? Ever tweeted a picture of a swollen or discolored part of your body? Continue reading “Finding Adverse Event Data on Social Media” »

  1. 1
  2. 2